
Last Price
52 Week Range
$0.95 - $3.00
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | $16.73M |
EV | - |
Shares Outstanding | 12.58M |
Beta | - |
Industry | Drug Manufacturers - Specialty & Generic |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y

Apimeds Pharmaceuticals US, Inc.
APUS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Menon, Vinod
Employees
Website
www.mindwavedao.comIPO Date
2025-05-09
Headquarters
B4-204A5, Business Centre 04, RAKEZ Business Zone-FZ, Ras Al Khaimah United Arab Emirates
The current price of Apimeds Pharmaceuticals US (APUS) is $1.88, reflecting a +0.00% change compared to the previous close. Last updated: April 10, 2026 at 11:45 AM Eastern Time
Review of Recent APUS Stock Performance trends:Past 1 Month: Apimeds Pharmaceuticals US (APUS) shares changed by -17.90%.Past 3 Months: The stock recorded a change of -37.85%.Past 6 Months: APUS shares posted a change of -30.37%. Last updated: March 7, 2026 at 7:03 PM Eastern Time
Over the last year, Apimeds Pharmaceuticals US (APUS) has established a 52-week price range between a high of $3.00 and a low of $0.95. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 7:03 PM Eastern Time
The current Apimeds Pharmaceuticals US (APUS) market capitalization is approximately $16.73M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Apimeds Pharmaceuticals US's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 7:03 PM Eastern Time
Apimeds Pharmaceuticals US's (APUS) earnings reports, including quarterly and annual financial statements, are available through the company's official regulatory filings with the U.S. Securities and Exchange Commission (SEC). On Gainify, you can access Apimeds Pharmaceuticals US's full set of filings, including earnings releases, Form 10-Q, Form 10-K, and other disclosures, in one place: Apimeds Pharmaceuticals US SEC Filings These filings provide detailed information on Apimeds Pharmaceuticals US's financial performance and are considered the primary source of verified financial data for publicly traded companies.
Apimeds Pharmaceuticals US (APUS) does not currently pay a dividend. Over the last twelve months (LTM), the company paid $0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, Apimeds Pharmaceuticals US (APUS) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 10, 2026 at 11:45 AM Eastern Time
Like other publicly traded stocks, Apimeds Pharmaceuticals US (APUS) shares are bought and sold on stock exchanges such as NYSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Apimeds Pharmaceuticals US (APUS) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add APUS to your watchlist.
Apimeds Pharmaceuticals US trades under the ticker symbol APUS on the NYSE stock exchange. The ticker APUS is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers